Twinbeech Capital LP Viatris Inc Transaction History

Twinbeech Capital LP

$4.99 Billion
Q3 2024

A detailed history of Twinbeech Capital LP transactions in Viatris Inc stock. As of the latest transaction made, Twinbeech Capital LP holds 273,327 shares of VTRS stock, worth $3.42 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

273,327

Holding current value

$3.42 Million

% of portfolio

0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.32 - $12.13 $2.82 Million - $3.32 Million	273,327 New	273,327 $3.17 Million
Q1 2024 May 15, 2024	BUY	$11.27 - $13.53 $7.73 Million - $9.28 Million	685,599 New	685,599 $8.19 Million
Q2 2023 Aug 14, 2023	SELL	$9.02 - $10.29 $2.3 Million - $2.62 Million	-254,983 Reduced 62.36%	153,875 $1.54 Million
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $11.4 Million - $15.2 Million	-1,240,300 Reduced 75.21%	408,858 $3.93 Million
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $12.6 Million - $16.7 Million	1,443,722 Added 702.76%	1,649,158 $18.4 Million
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $1.74 Million - $2.29 Million	205,436 New	205,436 $1.75 Million
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $6.4 Million - $10.1 Million	-652,741 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $1.17 Million - $1.42 Million	96,566 Added 17.36%	652,741 $8.83 Million
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $7.37 Million - $8.41 Million	556,175 New	556,175 $7.54 Million
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $3.11 Million - $3.87 Million	-239,850 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$13.59 - $18.54 $2.94 Million - $4.02 Million	216,622 Added 932.59%	239,850 $3.35 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $332,160 - $435,292	23,228 New	23,228 $435,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.

Account

Twinbeech Capital LP Viatris Inc Transaction History